The scent of love is in the air(way): a potential drug target for sleep apnea?

Amal M. Osman, Thomas J. Altree, Danny J. Eckert

Research output: Contribution to journalEditorial

2 Citations (Scopus)
75 Downloads (Pure)

Abstract


Fundamentally, obstructive sleep apnea (OSA) is characterized by the interaction between impaired pharyngeal anatomy and inadequate dilator muscle function during sleep [1]. Accordingly, strategies to reactivate upper airway dilator muscle activity during sleep are a key target for emerging pharmacotherapy for OSA [1–7]. Indeed, several preclinical, e.g. [8–12] and translational clinical proof of concept findings e.g. [2, 5, 6, 13–18] show considerable promise for the development of OSA pharmacotherapy.
Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalSLEEP
Volume46
Issue number4
DOIs
Publication statusPublished - Apr 2023

Keywords

  • obstructive sleep apnea (OSA)
  • OSA pharmacotherapy
  • sleep disordered breathing

Fingerprint

Dive into the research topics of 'The scent of love is in the air(way): a potential drug target for sleep apnea?'. Together they form a unique fingerprint.

Cite this